Table 1.
Clinical profile, SCORTEN, and clinical outcome parameters
| Age | Sex | Clinical diagnosis | Causal drug | Co-morbidity | SCORTEN at day 0 | Delay in admission (days) | Stabilization duration (days) | Reepithelization duration (days) | Hospital stay (days) |
|---|---|---|---|---|---|---|---|---|---|
| 35 | F | TEN | Phenytoin | MS | 2 | 3 | 5 | 14 | 17 |
| 30 | F | SJS/TEN | Nevirapine | HIV | 2 | 3 | 6 | 15 | 17 |
| 55 | M | TEN | Carbamazepine | HTN | 4 | 2 | 3 | 7 | 9 |
| 25 | F | SJS/TEN | Unknown | - | 2 | 5 | 5 | 9 | 15 |
| 40 | M | SJS | Carbamazepine | - | 1 | 4 | 3 | 7 | 9 |
| 35 | M | TEN | Unknown | - | 2 | 4 | 3 | 15 | 19 |
| 9 | M | SJS/TEN | Unknown | - | 1 | 3 | 4 | 9 | 13 |
| 46 | F | SJS | Efavirenz | HIV | 1 | 5 | 2 | 6 | 9 |
| 28 | M | TEN | Phenytoin | - | 2 | 4 | 5 | 15 | 18 |
| 22 | M | SJS | Unknown | - | 2 | 3 | 4 | 13 | 17 |
| 5 | M | SJS | Phenytoin | - | 1 | 3 | 3 | 7 | 9 |
| 44 | F | TEN | Carbamazepine | Diabetes | 3 | 3 | 5 | 11 | 13 |
| 11 | M | SJS | Paracetamol | - | 0 | 2 | 3 | 7 | 10 |
| 7 | M | TEN | Unknown | - | 1 | 4 | 3 | 8 | 10 |
| 63 | M | TEN | Carbamazepine | HTN | 4 | 7 | 5 | 15 | 18 |
| 25 | F | TEN | Itraconazole | - | 2 | 6 | 4 | 10 | 15 |